Primary Record
Levosulpiride
- In stock
- 7,161 g
- Purity
- 99.5 %
- CAS
- 23672-07-3
Compound Identifiers & Properties
- CAS
- 23672-07-3
- PubChem CID
- 688272
- SMILES
- CCN1CCC[C@H]1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC
- Canonical SMILES
- CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC
Names & Synonyms
- Levosulpiride
- (-)-Sulpiride
- (S)-(-)-sulpiride
- Levopraid
- Levopride
- Levosulpirida
- Levobren
- L-Sulpiride
- lesuride
- Levosulpiridum
- 23672-07-3
- S-(-)-Sulpiride
- (S)-sulpiride
- sulpiride
- Nexipride
- null
- S-Sulpiride
- Levogastrol
- Levosulpride
- Sulpiride l-form
- Sulpid
- Levosulpiride?
- Sulpiride, (s)-
- Sulpiride-l
- Sulpiride-S
- Levosulpiride [INN]
- Sulpiride, (-)-
- Sulpiride l-
- Levopraid (TN)
- S(-)-Sulpiride
- (-)-L-Sulpiride
- Levosulpiride (INN)
- JTG7R315LK
- Tocris-0895
- UNII-JTG7R315LK
- Sulpiride [L-(-)]
- AC1LELQ0
- Levosulpiridum [INN-Latin]
- RefChem:153234
- Levosulpirida [INN-Spanish]
- SULPIRIDE,(+)
- DTXSID0042583
- Biomol-NT_000030
- Levosulpiride (Levogastrol)
- BGRJTUBHPOOWDU-NSHDSACASA-N
- (RS)-(+/-)-sulpiride
- Lopac0_001089
- MFCD00055220
- SCHEMBL70112
- GTPL958
- CHEBI:64119
- MLS000759490
- MLS001424014
- LEVOSULPIRIDE [MART.]
- LEVOSULPIRIDE [WHO-DD]
- SULPIRIDE L-FORM [MI]
- BPBio1_001221
- CHEMBL267044
- orb1309390
- DTXCID8022583
- RV-12309
- SCHEMBL29406121
- BDBM81774
- C15H23N3O4S
- CTK8B3281
- ZINC57008
- N05AL07
- Levosulpiride - Bio-X trade mark
- HMS2051A08
- HMS2089E04
- HMS2232P10
- HMS3263I20
- HMS3266P14
- HMS3411D20
- HMS3675D20
- HMS3884H07
- ACN-S005456
- HY-B1059
- Tox21_110933
- Tox21_501089
- ANW-42196
- C15-H23-N3-O4-S
- CID688272
- CL-004
- EBC-13802
- HB1836
- NCGC00024853-05
- PDSP1_000516
- PDSP1_000620
- PDSP1_001649
- PDSP2_000514
- PDSP2_000616
- s2104
- SBB058180
- N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-2-methoxy-5-sulfamoylbenzamide
- AKOS007930553
- AKOS015897363
- Tox21_110933_1
- AC-6821
- BCP9000853
- CCG-100847
- CID:688272
- CS-4581
- CS-O-01769
- FL24886
- KS-5103
- LP01089
- NC00097
- SDCCGSBI-0051059.P002
- NCGC00015966-10
- NCGC00016718-01
- NCGC00024853-01
- NCGC00024853-02
- NCGC00024853-03
- NCGC00024853-04
- NCGC00024853-06
- NCGC00024853-09
- NCGC00024853-11
- NCGC00261774-01
- BL166176
- CPD000466366
- J60.441K
- SAM001246703
- SC-76846
- SMR000466366
- SY057391
- BCP0726000072
- SID:125240941
- 4-(2,2-Dichloro-vinyl)-thiazol-2-ylamine
- AB1009626
- CAS-15676-16-1
- CAS-23672-07-3
- CAS_15676-16-1
- TL8001954
- (S)-(-)-Sulpiride, >=98% (titration)
- B1484
- EU-0101089
- I0821
- NS00076154
- ST50319539
- SW197477-2
- (-)-N-(((S)-1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide
- (S)-(-)-N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide
- D07312
- H11356
- K-6442
- S 7771
- S-(-)-N-(1-Ethyl-2-pyrrolidinomethyl)-2-methoxy-5-sulfamoylebenzamide
- (S)-(-)-5-aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide
- AB00639965-06
- AB00639965-08
- AB00639965_09
- Benzamide, 5-(aminosulfonyl)-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-methoxy-
- EN300-7390775
- 672L073
- A816834
- C078143
- N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-methoxy-5-sulfamoylbenzamide
- SR-01000076136
- SR-01000597436
- A1201967
- Q1452256
- SR-01000076136-2
- SR-01000597436-1
- BRD-K51671335-001-01-5
- BRD-K51671335-001-04-9
- BRD-K51671335-001-09-8
- BRD-K51671335-001-10-6
- (S)-(-)-Sulpiride, VETRANAL(TM), analytical standard
- N-(((S)-1-ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide
- (S)-5-Aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide
- (S)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-methoxy-5-sulfamoylbenzamide
- (-)-N-[(1-Ethyl-2-pyrrolidinyl)methyl]-5-sulfamoyl-o-a nisamide
- (-)-N-[(1-Ethyl-2-pyrrolidinyl)methyl]-5-sulfamoyl-o-anisamide
- 5-(Aminosulfonyl)-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-methoxy-benzamide
- Benzamide, 5-(aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-, (S)-
- Benzamide, N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoyl-, S-(-)-
- N-[(1-ethylpyrrolidin-2-yl)methyl]-5-methoxy-2-sulfamoyl-benzamide
- (-)-5-Aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide
- (-)-N-[[(2S)-1-Ethyl-2-pyrrolidinyl]methyl]-5-sulfamoyl-o-anisamide
- (S)-N-[(1-Ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide
- 5-(Aminosulfonyl)-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-benzamide
- N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-methoxy-5-sulfamoyl-benzamide
- (S)-(-)-Sulpiride, 98%, a selective antagonist for D2 dopamine receptor - 25G 25g
- BENZAMIDE, 5-(AMINOSULFONYL)-N-(((2S)-1-ETHYL-2-PYRROLIDINYL)METHYL)-2-METHOXY-
- N-[((2S)-1-ethylpyrrolidin-2-yl)methyl](6-methoxy-3-sulfamoylphenyl)carboxamid e
- o-ANISAMIDE, N-((1-ETHYL-2-PYRROLIDINYL)METHYL)-5-SULFAMOYL-, (S)-(-)-
- 15676-16-1
- 5-(Aminosulfonyl)-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-methoxybenzamide; Benzamide, 5-(aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxy-, (S)-; o-Anisamide, N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-sulfamoyl-, (-)- (8CI); (-)-Sulpiride; L-Sulpiride; Lesuride; Levobren; Levopraid; Levosulpiride; S-(-)-Sulpiride; S-Sulpiride; l-Sulpiride; levopride; sulpid
- 5-HT6 Serotonin Receptor from rat, recombinant, expressed in HEK 293 cells, membrane suspension
- U6X